Project Grant HT94252410597
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The Department of the Army Medical Command awarded a $1,499,782 Project Grant to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery under the Military Medical Research and Development program. This three-year award beginning July 1, 2022 will support research into photosensitivity and lymph node immune responses in lupus. The Military Medical Research and Development program aims to advance biomedical research that improves health care for...
The U.S. Defense Health Agency awarded a $300,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery. The grant supports advanced biomedical research aimed at investigating novel mechanisms that prevent systemic lupus erythematosus (SLE). The award period is from Sep 1, 2025 to Aug 31, 2027. The Hospital for Special Surgery, a prominent non-profit...
The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
The Johns Hopkins University was awarded a $750,000 Project Grant from the Department of the Army Medical Command to study the role of complement in the antiphospholipid antibody syndrome in patients with systemic lupus erythematosus (SLE). The three-year award, issued on September 15, 2021 with a completion date of September 14, 2024, will fund research into medical solutions for the battlefield under the Military Medical Research and Development program (CFDA 12.420). This program supports...
The Department of the Army Medical Command awarded a $750,000 Project Grant to The Trustees of Columbia University in the City of New York under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant aims to validate Systemic Lupus Erythematosus (SLE) virtual outcome measures through three specific objectives over a three-year period ending August 2024. Sub-awards were provided to six institutions, including the Oklahoma Medical Research Foundation and the...